| Trial name or title | A 12‐week, randomized, double‐blind, placebo‐controlled, efficacy and safety study of fluticasone propionate multidose dry powder inhaler compared with fluticasone propionate/salmeterol multidose dry powder inhaler in patients aged 4 through 11 years with persistent asthma |
| Methods | Parallel‐arm randomised trial |
| Participants | Children aged 4 to 11 with persistent asthma |
| Interventions | Fluticasone propionate/salmeterol multidose dry powder inhaler |
| Outcomes | Fluticasone propionate multidose dry powder inhaler |
| Starting date | 16 December 2016 |
| Contact information | Teva |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.